argenx SE (ARGX)
605.92
+9.18
(+1.54%)
USD |
NASDAQ |
Nov 22, 16:00
597.01
-8.91
(-1.47%)
After-Hours: 20:00
argenx Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 534.31M |
| December 31, 2023 | 444.95M |
| June 30, 2023 | 335.74M |
| December 31, 2022 | 320.56M |
| June 30, 2022 | 279.02M |
| December 31, 2021 | 316.05M |
| June 30, 2021 | 261.09M |
| December 31, 2020 | 605.36M |
| June 30, 2020 | 456.61M |
| December 31, 2019 | 429.81M |
| June 30, 2019 | 390.84M |
| June 30, 2019 | 390.84M |
| December 31, 2018 | 45.83M |
| Date | Value |
|---|---|
| June 30, 2018 | 31.29M |
| June 30, 2018 | 31.29M |
| December 31, 2017 | 31.16M |
| June 30, 2017 | 40.30M |
| December 31, 2016 | 44.59M |
| June 30, 2016 | 46.64M |
| December 31, 2015 | 9.494M |
| June 30, 2015 | 11.60M |
| December 31, 2014 | 10.25M |
| June 30, 2014 | 14.12M |
| March 31, 2014 | 3.668M |
| December 31, 2013 | 4.568M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
261.09M
Minimum
Jun 2021
605.36M
Maximum
Dec 2020
398.35M
Average
382.77M
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 6.628M |
| uniQure NV | 589.98M |
| ProQR Therapeutics NV | 91.44M |
| Akari Therapeutics PLC | 9.428M |
| Merus NV | 141.42M |